Reduction of primary nonfunction in discordant pancreas islet xenografts.
Pittman
K
K
Department of Surgery, East Carolina University School of Medicine, Greenville, NC 27858.
Thomas
J
J
Thomas
F
F
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002469:Cell Separation; D002478:Cells, Cultured; D006146:Guanidines / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000166:cytology; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D051381:Rats; D011917:Rats, Inbred Lew; D013156:Splenectomy; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology / Q000502:physiology
D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus